Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.69 -0.01 (-0.07%)
At close: Sep 30, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Current Deferred Revenue (2018 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) posted Current Deferred Revenue of $6.28 million for Q2 2026, down 44.3% from $11.26 million a year earlier and down 17.5% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Current Deferred Revenue (2018 - 2026) Analysis & Trends

At the end of FY2025, Arcturus Therapeutics Holdings' Current Deferred Revenue came in at $8.25 million, down 57.7% from FY2024.

  • Annual Current Deferred Revenue shows a five-year compound annual growth rate of -14.6% (FY2020 to FY2025).
  • In prior years, Arcturus Therapeutics Holdings' Current Deferred Revenue was $19.51 million in FY2024 (-56.5%), $44.83 million in FY2023 (+56.5%), $28.65 million in FY2022 (-34.1%) and $43.48 million in FY2021 (+140.1%).
  • The Q2 2026 figure stands as the lowest quarterly Current Deferred Revenue since Q3 2022.
  • On a year-over-year basis, Current Deferred Revenue has declined in each of the last nine quarters, with an average decline of 57.8% over the last eight quarters.
  • The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q3 2021, with growth of 911.2%; the weakest was Q3 2022, with a decline of 91.9%.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $7.61 million (Q1 2026), $8.25 million (Q4 2025) and $6.83 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Arcturus Therapeutics Holdings 389.40 Mn -424.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.28 Mn
Mar 31, 2026 7.61 Mn
Dec 31, 2025 8.25 Mn
Sep 30, 2025 6.83 Mn
Jun 30, 2025 11.26 Mn
Mar 31, 2025 12.67 Mn
Dec 31, 2024 19.51 Mn
Sep 30, 2024 26.94 Mn
Jun 30, 2024 42.36 Mn
Mar 31, 2024 71.52 Mn
Dec 31, 2023 44.83 Mn
Sep 30, 2023 40.77 Mn
Jun 30, 2023 47.96 Mn
Mar 31, 2023 38.49 Mn
Dec 31, 2022 28.65 Mn
Sep 30, 2022 4.66 Mn
Jun 30, 2022 26.35 Mn
Mar 31, 2022 53.06 Mn
Dec 31, 2021 43.48 Mn
Sep 30, 2021 57.62 Mn
API Access

Arcturus Therapeutics Holdings Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=ARCT&period=max&api_key=YOUR_API_KEY